42 results
424B5
OVID
Ovid Therapeutics Inc
15 Nov 23
Prospectus supplement for primary offering
4:11pm
, the business combination is approved by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written … if less than a quorum;
require that any action to be taken by our stockholders must be effected at a duly called annual or special meeting
424B5
wrr4kmm4za 346t2
20 Nov 20
Prospectus supplement for primary offering
4:23pm
424B5
1ym7m8u xw
26 Aug 20
Prospectus supplement for primary offering
4:07pm